BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bristol-Myers Squibb Company (BMY) To Host Research And Development Overview With Financial Analysts On November 17, 2004


10/19/2005 5:12:11 PM

NEW YORK, Nov. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company is hosting a meeting for the investment community at 8 a.m. on Wednesday, November 17 to provide a comprehensive update on the company's research and development efforts. Bristol-Myers Squibb executives will provide a complete overview of near and long-term prospects in the company's pipeline, including developmental medicines for cancer, diabetes, hepatitis B, rheumatoid arthritis, cardiovascular disease and other therapeutic areas.

For more information on the meeting, please visit the company's Investor Relations web site at http://www.bms.com/ir. Investors are invited to listen to a live webcast of the presentation, which also can be accessed at http://www.bms.com/ir. In addition, a replay of the presentation will be available until December 15, 2004.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

Bristol-Myers Squibb Company

CONTACT: Media: Brian Henry, Corporate Affairs, +1-609-252-3337,brian.henry@bms.com; or Investor: John Elicker, Investor Relations,+1-212-546-3775, john.elicker@bms.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES